Annual Non Current Assets
$14.50 M
+$3.60 M+32.96%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual long term assets is $14.50 million, with the most recent change of +$3.60 million (+32.96%) on December 31, 2023.
- During the last 3 years, PLX annual non current assets has risen by +$2.29 million (+18.76%).
- PLX annual non current assets is now -24.91% below its all-time high of $19.31 million, reached on December 31, 2011.
Performance
PLX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$13.71 M
-$463.00 K-3.27%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly long term assets is $13.71 million, with the most recent change of -$463.00 thousand (-3.27%) on September 30, 2024.
- Over the past year, PLX quarterly non current assets has dropped by -$1.24 million (-8.30%).
- PLX quarterly non current assets is now -45.40% below its all-time high of $25.11 million, reached on March 31, 2020.
Performance
PLX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
PLX Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +33.0% | -8.3% |
3 y3 years | +18.8% | -8.3% |
5 y5 years | +78.0% | -8.3% |
PLX Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +33.0% | -8.3% | +25.7% |
5 y | 5-year | at high | +33.0% | -45.4% | +25.7% |
alltime | all time | -24.9% | -100.0% | -45.4% | -100.0% |
Protalix BioTherapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $13.71 M(-3.3%) |
Jun 2024 | - | $14.17 M(-1.7%) |
Mar 2024 | - | $14.42 M(-0.6%) |
Dec 2023 | $69.93 M(+55.8%) | $14.50 M(-3.0%) |
Sep 2023 | - | $14.95 M(+0.7%) |
Jun 2023 | - | $14.84 M(+33.0%) |
Mar 2023 | - | $11.16 M(+2.3%) |
Dec 2022 | $44.88 M(-27.2%) | $10.91 M(-0.4%) |
Sep 2022 | - | $10.95 M(+0.1%) |
Jun 2022 | - | $10.94 M(-7.7%) |
Mar 2022 | - | $11.85 M(-1.3%) |
Dec 2021 | $61.67 M(+10.7%) | $12.00 M(-2.1%) |
Sep 2021 | - | $12.26 M(-0.2%) |
Jun 2021 | - | $12.28 M(+1.5%) |
Mar 2021 | - | $12.09 M(-1.0%) |
Dec 2020 | $55.72 M(+71.6%) | $12.21 M(+1.9%) |
Sep 2020 | - | $11.98 M(-31.6%) |
Jun 2020 | - | $17.50 M(-30.3%) |
Mar 2020 | - | $25.11 M(+94.4%) |
Dec 2019 | $32.48 M(-38.7%) | $12.91 M(-2.8%) |
Sep 2019 | - | $13.29 M(-2.6%) |
Jun 2019 | - | $13.64 M(-0.4%) |
Mar 2019 | - | $13.70 M(+68.2%) |
Dec 2018 | $52.98 M(-15.4%) | $8.15 M(-17.3%) |
Sep 2018 | - | $9.86 M(+13.7%) |
Jun 2018 | - | $8.67 M(-4.8%) |
Mar 2018 | - | $9.11 M(-4.7%) |
Dec 2017 | $62.65 M(-12.8%) | $9.56 M(-3.5%) |
Sep 2017 | - | $9.90 M(-2.0%) |
Jun 2017 | - | $10.11 M(-1.9%) |
Mar 2017 | - | $10.31 M(-0.7%) |
Dec 2016 | $71.87 M(-16.3%) | $10.38 M(-4.1%) |
Sep 2016 | - | $10.83 M(-3.5%) |
Jun 2016 | - | $11.22 M(+1.6%) |
Mar 2016 | - | $11.04 M(-2.9%) |
Dec 2015 | $85.88 M(+31.1%) | $11.37 M(-2.1%) |
Sep 2015 | - | $11.62 M(-3.9%) |
Jun 2015 | - | $12.09 M(-3.0%) |
Mar 2015 | - | $12.46 M(-2.9%) |
Dec 2014 | $65.52 M(-33.1%) | $12.84 M(-5.5%) |
Sep 2014 | - | $13.59 M(-4.9%) |
Jun 2014 | - | $14.29 M(-3.8%) |
Mar 2014 | - | $14.86 M(-3.7%) |
Dec 2013 | $97.90 M(+60.1%) | $15.43 M(-3.3%) |
Sep 2013 | - | $15.96 M(-2.6%) |
Jun 2013 | - | $16.37 M(-4.0%) |
Mar 2013 | - | $17.05 M(-2.9%) |
Dec 2012 | $61.17 M(+88.3%) | $17.56 M(-1.4%) |
Sep 2012 | - | $17.80 M(-3.3%) |
Jun 2012 | - | $18.41 M(-1.1%) |
Mar 2012 | - | $18.63 M(-3.6%) |
Dec 2011 | $32.49 M | $19.31 M(-6.0%) |
Sep 2011 | - | $20.55 M(-0.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | $20.69 M(+10.8%) |
Mar 2011 | - | $18.67 M(+1.5%) |
Dec 2010 | $46.33 M(-44.5%) | $18.40 M(+10.1%) |
Sep 2010 | - | $16.71 M(+7.8%) |
Jun 2010 | - | $15.50 M(+0.3%) |
Mar 2010 | - | $15.45 M(+1.3%) |
Dec 2009 | $83.41 M(+92.2%) | $15.26 M(+19.0%) |
Sep 2009 | - | $12.83 M(+15.5%) |
Jun 2009 | - | $11.11 M(+24.3%) |
Mar 2009 | - | $8.94 M(+20.4%) |
Dec 2008 | $43.39 M(-31.3%) | $7.42 M(+7.1%) |
Sep 2008 | - | $6.93 M(+6.0%) |
Jun 2008 | - | $6.54 M(+10.0%) |
Mar 2008 | - | $5.95 M(+19.7%) |
Dec 2007 | $63.17 M(+160.0%) | $4.97 M(+19.3%) |
Sep 2007 | - | $4.17 M(+15.9%) |
Jun 2007 | - | $3.59 M(+11.7%) |
Mar 2007 | - | $3.22 M(+19.3%) |
Dec 2006 | $24.29 M(+386.3%) | $2.70 M(>+9900.0%) |
Sep 2006 | - | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(-100.0%) |
Dec 2005 | $5.00 M(+782.5%) | $2.23 M(>+9900.0%) |
Sep 2005 | - | $0.00(0.0%) |
Jun 2005 | - | $0.00(0.0%) |
Mar 2005 | - | $0.00(0.0%) |
Dec 2004 | $566.00 K(-22.9%) | $0.00(0.0%) |
Sep 2004 | - | $0.00(0.0%) |
Jun 2004 | - | $0.00(0.0%) |
Mar 2004 | - | $0.00(0.0%) |
Dec 2003 | $734.30 K(-11.7%) | $0.00(0.0%) |
Sep 2003 | - | $0.00(0.0%) |
Jun 2003 | - | $0.00(0.0%) |
Mar 2003 | - | $0.00(-100.0%) |
Dec 2002 | $832.00 K(-13.0%) | $43.30 K(-12.3%) |
Sep 2002 | - | $49.40 K(-10.7%) |
Jun 2002 | - | $55.30 K(-9.6%) |
Mar 2002 | - | $61.20 K(-8.8%) |
Dec 2001 | $956.10 K(-46.9%) | $67.10 K(-55.0%) |
Sep 2001 | - | $149.20 K(+84.0%) |
Jun 2001 | - | $81.10 K(-6.1%) |
Mar 2001 | - | $86.40 K(-17.9%) |
Dec 2000 | $1.80 M(+9.4%) | $105.30 K(-12.0%) |
Sep 2000 | - | $119.70 K(-51.1%) |
Jun 2000 | - | $244.70 K(-30.3%) |
Mar 2000 | - | $351.20 K(-13.1%) |
Dec 1999 | $1.64 M(-36.4%) | $404.30 K(-45.0%) |
Sep 1999 | - | $735.30 K(-24.7%) |
Jun 1999 | - | $976.00 K(-50.9%) |
Mar 1999 | - | $1.99 M |
Dec 1998 | $2.59 M(-65.2%) | - |
Dec 1997 | $7.43 M(+1.3%) | - |
Dec 1996 | $7.33 M | - |
FAQ
- What is Protalix BioTherapeutics annual long term assets?
- What is the all time high annual non current assets for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual non current assets year-on-year change?
- What is Protalix BioTherapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly non current assets year-on-year change?
What is Protalix BioTherapeutics annual long term assets?
The current annual non current assets of PLX is $14.50 M
What is the all time high annual non current assets for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual long term assets is $19.31 M
What is Protalix BioTherapeutics annual non current assets year-on-year change?
Over the past year, PLX annual long term assets has changed by +$3.60 M (+32.96%)
What is Protalix BioTherapeutics quarterly long term assets?
The current quarterly non current assets of PLX is $13.71 M
What is the all time high quarterly non current assets for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly long term assets is $25.11 M
What is Protalix BioTherapeutics quarterly non current assets year-on-year change?
Over the past year, PLX quarterly long term assets has changed by -$1.24 M (-8.30%)